Your browser doesn't support javascript.
loading
A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness.
Constantinou, Costas A; Ziogas, Dimitrios C; Venetsanopoulou, Aliki; Gamaletsou, Maria N; Koutsogeorgopoulou, Loukia; Barbouni, Anastasia; Tzioufas, Athanasios G; Sipsas, Nikolaos V.
Afiliação
  • Constantinou CA; Department of Pathophysiology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece.
  • Ziogas DC; First Department of Internal Medicine, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece. Electronic address: ziogasdc@gmail.com.
  • Venetsanopoulou A; Department of Pathophysiology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece.
  • Gamaletsou MN; Department of Pathophysiology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece.
  • Koutsogeorgopoulou L; Department of Pathophysiology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece.
  • Barbouni A; National School of Public Health, University of West Attica, Athens, Greece.
  • Tzioufas AG; Department of Pathophysiology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece.
  • Sipsas NV; Department of Pathophysiology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital, Athens, Greece.
Vaccine ; 39(11): 1593-1597, 2021 03 12.
Article em En | MEDLINE | ID: mdl-33610375
INTRODUCTION: Patients with autoimmune rheumatic diseases (ARDs) are at increased risk for pneumococcal infections and should be vaccinated against Streptococcus pneumoniae. Data on the rates of pneumococcal vaccination among patients with ARDs in Southern Europe are scarce. Here, we estimate the pneumococcal vaccination rate in patients living in Greece with ARDs, explore the patients' awareness regarding vaccination, and try to recognize factors that influence the vaccine uptake. METHODS: Between October 2015 and September 2016, a structured questionnaire was provided to all consecutive patients with ARDs attending one outpatient clinic of our department. The survey included parameters concerning patients' demographics, underlying ARD and immunosuppressive medications, other comorbidities, vaccine type, knowledge about infection risk and necessity of vaccination. Univariate and multivariate analyses were performed to study any association of these factors with the vaccination uptake. RESULTS: Overall, 395 patients with ARDs (30.13% aged >65 years and 78.99% female) participated in our survey. The most frequent ARD was rheumatoid arthritis (43.04%); 40.51% of patients were receiving biologic agents and 44.56% steroids. Pneumococcal vaccination rate was 49.37%, while 45.06% of patients have been vaccinated during the last five years and only 8.21% of them had a second pneumococcal vaccine, as per national guidelines. The decision of vaccination was significantly influenced by the patient's age (>65 years) (p < 0.001) and the complete awareness of reasons for being vaccinated (p < 0.001), but not by presence of comorbidities, the type of ARD or administration of a biologic agent. The main reason for no vaccination was that it was not suggested by the caring physician (82.50%). CONCLUSIONS: In our cohort of patients with ARDs the pneumococcal vaccination was suboptimal. Better understanding of the significance of vaccination by the patient and suggestion for vaccination by the caring physician will improve vaccination uptake and optimize the clinical benefits among patients with ARDs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacinas contra Influenza Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacinas contra Influenza Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article